Article (Scientific journals)
Application of EU Competition Law in the Pharmaceutical Sector
Hull, David; Clancy, Michael J.
2016In Journal of European Competition Law and Practice, 7, p. 153-161
Peer Reviewed verified by ORBi
 

Files


Full Text
European Pharma Antitrust Survey 2015-1.pdf
Publisher postprint (143.67 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Pharmaceutical Sector; EU competition law
Abstract :
[en] This survey article reviews the major EU competition law developments in the pharmaceutical sector from 1 July 2014 through 31 October 2015 as well as decisions that were adopted earlier but only published during the period. The European Commission did not adopt any decisions dealing with the pharmaceutical sector during this period, but published its decisions in Lundbeck, Servier and J&J/Novartis, which are a rich source of information on how the Commission approaches IP, regulatory and commercial strategies that delay generic entry. National competition authorities continue to be active, notably in the area of pricing and distribution/parallel trade.
Disciplines :
European & international law
Economic & commercial law
Author, co-author :
Hull, David ;  Université de Liège - ULiège > Département de droit > Droit international et droit comparé de la concurrence
Clancy, Michael J.
Language :
English
Title :
Application of EU Competition Law in the Pharmaceutical Sector
Publication date :
2016
Journal title :
Journal of European Competition Law and Practice
ISSN :
2041-7764
eISSN :
2041-7772
Publisher :
Oxford University Press, Oxford, United Kingdom
Volume :
7
Pages :
153-161
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 13 May 2019

Statistics


Number of views
251 (1 by ULiège)
Number of downloads
735 (2 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
1
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi